Navigation Links
Ajinomoto Co., Inc. Harnesses Amino Acid Power to Improve Sleep

FORT LEE, N.J., May 31, 2011 /PRNewswire/ -- Ajinomoto Food Ingredients announced that Ajinomoto Co., Inc., a leader in the development of pharmaceutical-quality amino acids and safe, effective nutraceutical solutions, will showcase Glysom™ ( during Sleep 2011, the 25th Annual Meeting of the Associated Professional Sleep Societies to be held in Minneapolis, June 11-15, 2011.

Glysom™ is the latest breakthrough in amino acid and sleep research.  Made from glycine, an amino acid that occurs naturally in the body, Glysom™ is scientifically proven to promote deeper, sounder and more satisfying sleep for occasional sleeplessness without morning drowsiness.* Developed by a team of Ajinomoto Co., Inc. scientists led by Dr. Makoto Bannai, one of the foremost authorities on glycine and its applications to sleep, Glysom™ is particularly effective in promoting the deep, non-REM sleep crucial to feeling refreshed and restored in the morning.*  

"Since not all sleep is created equal, it's not enough to simply increase the number of hours at sleep," said Brendan Naulty, president of Ajinomoto Food Ingredients.  "Glysom™ zeroes in on sleep quality, inducing the healthy deep sleep critical to optimal well-being."

Glycine, the amino acid that is produced naturally in the body and present in many healthy foods such as fish, meat and bean, has been extensively researched.  Dr. Bannai has led glycine research at Ajinomoto Co., Inc. since 2005.  In the past decade, he has authored or co-authored over 20 studies examining various mechanisms of improving sleep and the critical connection between glycine and enhanced sleep quality and daytime performance.   Among Dr. Bannai's key findings are an early appearance of slow wave sleep (SWS) and the reduction of deep (core) body temperature in early phases of sleep after glycine ingestion, all indicators of improved sleep quality.

Introduced in the US in May 2010, Glysom™ is available exclusively through medical professionals.  In the year since its introduction, approximately 70 medical establishments nationwide have begun recommending Glysom™ to patients who experience occasional sleeplessness.  

According to the Centers for Disease Control and Prevention (the CDC), insufficient sleep is a public health epidemic, with an estimated 50-70 million US adults having difficulties with sleep or wakefulness.  

In addition to Glysom™, Ajinomoto Food Ingredients' safe, effective nutraceutical solutions include Capsiate Natura®, a patented, side effect-free dietary supplement with natural capsinoids shown to boost the body's metabolism*; and Natura Guard BP™, a milk protein-derived nutraceutical to help maintain healthy blood pressure levels already within the normal range*.  These products are backed by rigorous clinical studies and are available exclusively through medical professionals.  For more information and a complete list of healthcare professionals that carry Ajinomoto Food Ingredients' nutraceuticals, visit, and

About Ajinomoto Food Ingredients

Ajinomoto Food Ingredients delivers safe, effective ingredients whose functionality has been scientifically proven.  Our mission is the pursuit of better health through better nutrition.  Beginning with AJI-NO-MOTO® MSG, a highly versatile seasoning, our products have diversified to flavor seasonings (bonito, pork, chicken, and beef), sweeteners, savory sauces, enzymes, other food ingredients and nutritional supplements.  Based on the five basic tastes centering on Umami, Ajinomoto supplies ingredients with unique aroma, texture, kokumi (full-bodied taste) and nutritional functionality.  These ingredients make it possible for our customers to build strong brands and offer consumers great-tasting, nutritionally beneficial products.

About Ajinomoto Co., Inc.

Ajinomoto is a global manufacturer of high-quality seasonings, processed foods, beverages, amino acids, pharmaceuticals and specialty chemicals.  For many decades, Ajinomoto has contributed to food culture and human health through wide-ranging application of amino acid technologies.  Today, the company is becoming increasingly involved with solutions for improved food resources, human health and global sustainability.  Founded in 1909 and now operating in 23 countries, Ajinomoto had net sales of 1,170.8 billion yen (12.8 billion USD) in fiscal 2010.  For more about Ajinomoto (TYO: 2802), visit

Glysom™ clinical studies are available on request.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

SOURCE Ajinomoto Co., Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Ajinomoto Co.s Capsiate Natura® Reaches New Milestone
2. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
3. Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule
4. Research Team Clones Genes Responsible for Amino Acid Absorption
5. Abbott Receives Complete Response Letter From FDA for Controlled-Release Hydrocodone With Acetaminophen
6. El Camino Hospital Expands Robotic Surgery Program
7. Cadence Pharmaceuticals Announces FDA Extends New Drug Application Review for Intravenous Acetaminophen by Three Months
8. Cysview(TM) (Hexaminolevulinate HCl) Approved by the FDA for Cystoscopic Detection of Papillary Bladder Cancer
9. FDA Limits Acetaminophen in Prescription Combination Products; Requires Liver Toxicity Warnings
10. FDA Consumer Health Information - New Steps Aimed at Cutting Risks from Acetaminophen
11. Abuse Deterrent Hydrocodone / Acetaminophen Leads NDA Pipeline
Post Your Comments:
(Date:11/25/2015)... 25, 2015  Amgen (NASDAQ: AMGN ) today ... with the United States (U.S.) ... biosimilar candidate to Humira ® (adalimumab). Amgen believes ... to the FDA and represents Amgen,s first BLA submission ... Harper , M.D., executive vice president of Research and ...
(Date:11/25/2015)... , Nov. 25, 2015 AAIPharma Services ... investment of at least $15.8  Million to expand ... Wilmington, NC . The expansion will provide ... meet the growing demands of the pharmaceutical and ... site expansion will provide up to 40,000 square ...
(Date:11/25/2015)...  Henry Schein, Inc., the world,s largest provider of ... and animal health practitioners, will unveil at the Greater ... ConnectDental® Pavilion , which brings together for the first ... to help any practice or laboratory enter the digital ... schedule of experts appearing at the Pavilion. --> ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... 2015 , ... The McHenry County law firm of Botto Gilbert Lancaster, ... Francisco J. Botto and Alex C. Wimmer. Attorneys Botto and Wimmer represented the claimant ... (2d) 130884WC. , According to court documents, Adcock testified that on May 10, 2010 ...
(Date:11/25/2015)... ... November 25, 2015 , ... SCOTTSDALE, AZ) - Today, ... specializing in both surgical and non-surgical treatments, announced the expansion of his private ... Plastic Surgery. , Highly trained and nationally recognized for his natural approach, ...
(Date:11/25/2015)... ... November 25, 2015 , ... In an ongoing Clinical ... Center (RMC) in Chicago, IL, UV Angel is evaluating the efficacy of its product ... intensive care units (totaling 30 beds) from May 2014 through October 2015 at a ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... provide scholarships for people struggling with eating disorders as a result of the ... second annual event, held at Fox Run Golf Club in Eureka, will help ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... that it has undertaken significant expansion of its current state of the art ... part of PharmaTech’s strategy to increase its manufacturing capacity as well as to ...
Breaking Medicine News(10 mins):